AXOGEN ($AXGN) posted quarterly earnings results for Q1 2026 on Tuesday, April 28th. The company reported earnings of $0.07 per share, missing estimates of $0.07 by $0.00. The company also reported revenue of $61,460,000, beating estimates of $58,879,948 by $2,580,052.
You can see Quiver Quantitative's $AXGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AXOGEN Insider Trading Activity
AXOGEN insiders have traded $AXGN stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:
- MICHAEL D DALE (Chief Executive Officer) has made 0 purchases and 2 sales selling 86,463 shares for an estimated $2,668,137.
- WILLIAM P. MR. BURKE has made 0 purchases and 7 sales selling 98,079 shares for an estimated $2,197,869.
- JOHN JOHNSON has made 0 purchases and 4 sales selling 45,379 shares for an estimated $1,390,392.
- KATHY JOHNSON WEILER has made 0 purchases and 3 sales selling 46,653 shares for an estimated $1,378,475.
- AMY MCBRIDE WENDELL has made 0 purchases and 3 sales selling 43,684 shares for an estimated $1,280,465.
- LINDSEY MARIE HARTLEY (CFO) has made 0 purchases and 3 sales selling 29,199 shares for an estimated $896,298.
- ERICK WAYNE DEVINNEY (Chief Innovation Officer) has made 0 purchases and 2 sales selling 24,738 shares for an estimated $780,544.
- JOSEPH A. TYNDALL has made 0 purchases and 2 sales selling 25,108 shares for an estimated $777,770.
- MARC A BEGAN (EVP & General Counsel) has made 0 purchases and 2 sales selling 22,500 shares for an estimated $686,207.
- PAUL THOMAS sold 21,399 shares for an estimated $633,709
- JENS KEMP (Chief Marketing Officer) sold 8,156 shares for an estimated $254,532
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
AXOGEN Hedge Fund Activity
We have seen 115 institutional investors add shares of AXOGEN stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 933,778 shares (+101.1%) to their portfolio in Q1 2026, for an estimated $30,936,065
- MILLENNIUM MANAGEMENT LLC added 930,126 shares (+2255.8%) to their portfolio in Q4 2025, for an estimated $30,443,023
- NEXT CENTURY GROWTH INVESTORS LLC added 799,882 shares (+inf%) to their portfolio in Q4 2025, for an estimated $26,180,137
- PERCEPTIVE ADVISORS LLC added 784,140 shares (+inf%) to their portfolio in Q4 2025, for an estimated $25,664,902
- CAPRICORN FUND MANAGERS LTD added 687,600 shares (+inf%) to their portfolio in Q1 2026, for an estimated $22,780,188
- FIRST LIGHT ASSET MANAGEMENT, LLC removed 572,404 shares (-9.9%) from their portfolio in Q4 2025, for an estimated $18,734,782
- BALYASNY ASSET MANAGEMENT L.P. removed 532,188 shares (-38.6%) from their portfolio in Q4 2025, for an estimated $17,418,513
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
AXOGEN Analyst Ratings
Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 12/05/2025
- Mizuho issued a "Outperform" rating on 12/01/2025
To track analyst ratings and price targets for AXOGEN, check out Quiver Quantitative's $AXGN forecast page.
AXOGEN Price Targets
Multiple analysts have issued price targets for $AXGN recently. We have seen 7 analysts offer price targets for $AXGN in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- Frank Takkinen from Lake Street set a target price of $50.0 on 04/23/2026
- Caitlin Cronin from Canaccord Genuity set a target price of $40.0 on 03/30/2026
- David Turkaly from Citizens set a target price of $42.0 on 02/24/2026
- Larry Biegelsen from Wells Fargo set a target price of $40.0 on 02/19/2026
- Yi Chen from HC Wainwright & Co. set a target price of $39.0 on 12/05/2025
- Michael Sarcone from Jefferies set a target price of $36.0 on 12/04/2025
- Anthony Petrone from Mizuho set a target price of $40.0 on 12/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
